Prolactinoma in a man following industrial exposure to estrogens.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Western Journal of Medicine

• Publication date

  1983-05-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  PMID 6880188PMCID PMC1010808
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Noninvasive diagnosis of left atrial myxoma.

  1983cited by this paper
• Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series.

  1981cited by this paper
• Oral contraceptives and pituitary adenomas.

  1980cited by this paper
• The amenorrhea, galactorrhea and hyperprolactinemia syndromes.

  1980cited by this paper
• Evaluation and Treatment of Patients with Prolactin‐Secreting Pituitary Tumors

  1980cited by this paper
• Oral contraceptive history as a risk indicator in patients with pituitary tumors with hyperprolactinemia: a case comparison study of twenty patients.

  1980cited by this paper
• Selective transsphenoidal adenomectomy in women with galactorrhea-amenorrhea.

  1979cited by this paper
• Estrogen inhibition of dopamine release into hypophysial portal blood.

  1979cited by this paper
• Pituitary adenoma and oral contraceptives: a case-control study.

  1979cited by this paper
• Effects of estrogen on primary ovine pituitary cell cultures: stimulation of prolactin secretion, synthesis, and preprolactin messenger ribonucleic acid activity.

  1979cited by this paper
• Prolactin-secreting tumors and hypogonadism in men.

  1979cited by this paper
• In vivo effects of estrogen on ovine pituitaries: prolactin and growth hormone biosynthesis and messenger ribonucleic acid translation.

  1979cited by this paper
• Estrogen-induced galactorrhea in man.

  1979cited by this paper
• Estrogen control of prolactin synthesis in vitro.

  1978cited by this paper
• Prolactin-screening tumors and hypogonadism in 22 men.

  1978cited by this paper
• Pathogenesis of prolactin-secreting pituitary adenomas.

  1978cited by this paper
• Impact of new diagnostic methods on the differential diagnosis and treatment of secondary amenorrhoea.

  1977cited by this paper
• Effect of estradiol-17 beta on preprolactin messenger ribonucleic acid activity in the rat pituitary gland.

  1977cited by this paper
• Detection, evaluation, and treatment of pituitary microadenomas in patients with galactorrhea and amenorrhea.

  1977cited by this paper
• Effects of estradiol-17beta and pimozide on prolactin synthesis in male and female rats.

  1977cited by this paper
• Galactorrhea: a study of 235 cases, including 48 with pituitary tumors.

  1977cited by this paper
• Pattern of increase in circulating prolactin levels during human gestation.

  1977cited by this paper
• Induction of Pituitary Tumors in Male Rats by a Single Dose of Estrogen

  1975cited by this paper
• The influence of exogenous estrogen on the circadian periodicity of circulating prolactin in women.

  1975cited by this paper
• Augmentation of prolactin secretion by estrogen in hypogonadal women.

  1974cited by this paper
• DEPLETION OF PROLACTIN-INHIBITING ACTIVITY OF RAT HYPOTHALAMUS BY ESTRADIOL OR SUCKLING STIMULUS.

  1964cited by this paper
• Estrogen stimulation of prolactin production by rat adenohypophysis in vitro.

  1962cited by this paper

• Characteristics of pericytes in diethylstilbestrol (DES)-induced pituitary prolactinoma in rats

  2018cites this paper
• Medical therapies in pituitary adenomas: Current rationale for the use and future perspectives.

  2015cites this paper
• Estrogen action in the regulation of cell proliferation, cell survival, and tumorigenesis in the rat anterior pituitary gland

  1999cites this paper
• Genetic bases of estrogen-induced pituitary growth in an intercross between the ACI and Copenhagen rat strains: dominant mendelian inheritance of the ACI phenotype.

  1999cites this paper
• The association of oral contraception with kidney cancer, colon cancer, gallbladder cancer (including extrahepatic bile duct cancer) and pituitary tumours.

  1991cites this paper